Immunostaining of peroxisome proliferator-activated receptor-coactivator1α (PGC1α) showed that APX-115 or losartan significantly restored diabetes-induced suppression of PGC1α in the kidney (Figure 7A and 7B). This evidence concerns the gene PPARGC1A and diabetes mellitus.